Generating Anti-CD19 CAR T Cells with High Efficiency and Viability via mRNA Electroporation

Name: Generating Anti-CD19 CAR T Cells with High Efficiency and Viability via mRNA Electroporation
Start: 2026-11-03
End: 2026-11-03

Starts: November 3, 2026
Ends: November 3, 2026
Format: Online
Location: VIRTUAL

About This Event

Nonviral delivery methods, such as electroporation, represent a potentially safer and less challenging approach for generating CAR T cells. Flexible, high-throughput technologies such as flow cytometry can greatly assist in reducing the challenges of CAR T-cell workflows.